Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids

Jean Pierre Devogelaer*, Philip Sambrook, David M. Reid, Stefan Goemaere, Sophia Ish-Shalom, Julien Collette, Guoqin Su, Christina Bucci-Rechtweg, Philemon Papanastasiou, Jean Yves Reginster

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids'. Together they form a unique fingerprint.

Medicine & Life Sciences